Oncimmune Holdings PLC (STU:OCY)
€ 0.143 -0.005 (-3.38%) Market Cap: 17.18 Mil Enterprise Value: 22.36 Mil PE Ratio: 1.17 PB Ratio: 0 GF Score: 42/100

Full Year 2021 Oncimmune Holdings PLC Earnings Call Transcript

Nov 02, 2021 / 10:00AM GMT
Release Date Price: €1.89 (-5.50%)
Operator

Good afternoon, ladies and gentlemen, and welcome to the Oncimmune Holdings full year results investor presentation. (Operator Instructions) I'd also like to remind you that this presentation is being recorded. Before we begin, we'd like to submit the following poll. And if you give that your kind attention, we would be most grateful. And I'd now like to hand over to Matthew Hall, CFO; and Dr. Adam Hill, CEO from Oncimmune. Good afternoon.

Adam Hill
Oncimmune Holdings plc - CEO

Many thanks for joining us. Ladies and gentlemen, my name's Adam Hill, and I'm joined by Matthew Hall. We've both been with the company for approximately 3.5 years during which we've led very much a turnaround of Oncimmune, and focused the company not just upon early detection but also upon the support of pharmaceutical companies that are currently pursuing clinical trials, and that second part of the business is very much the growth catalyst for us moving forward.

I'm going to spend the next couple of minutes just talking about what we've achieved over the reporting period and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot